Year |
Citation |
Score |
2008 |
Riddle EL, Fleckenstein AE, Hanson GR. Role of monoamine transporters in mediating psychostimulant effects Drug Addiction: From Basic Research to Therapy. 169-177. DOI: 10.1007/978-0-387-76678-2_11 |
0.671 |
|
2007 |
Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. The Journal of Pharmacology and Experimental Therapeutics. 323: 738-45. PMID 17693585 DOI: 10.1124/Jpet.107.126888 |
0.746 |
|
2007 |
Riddle EL, Hanson GR, Fleckenstein AE. Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. European Journal of Pharmacology. 571: 25-8. PMID 17618619 DOI: 10.1016/J.Ejphar.2007.05.044 |
0.719 |
|
2007 |
Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology. 47: 681-98. PMID 17209801 DOI: 10.1146/Annurev.Pharmtox.47.120505.105140 |
0.776 |
|
2006 |
Riddle EL, Fleckenstein AE, Hanson GR. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. The Aaps Journal. 8: E413-8. PMID 16808044 DOI: 10.1007/Bf02854914 |
0.673 |
|
2005 |
Riddle EL, Fleckenstein AE, Hanson GR. Role of monoamine transporters in mediating psychostimulant effects. The Aaps Journal. 7: E847-51. PMID 16594636 DOI: 10.1208/Aapsj070481 |
0.771 |
|
2004 |
Hanson GR, Sandoval V, Riddle E, Fleckenstein AE. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications. Annals of the New York Academy of Sciences. 1025: 146-50. PMID 15542712 DOI: 10.1196/Annals.1316.019 |
0.81 |
|
2004 |
Baucum AJ, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3436-43. PMID 15056723 DOI: 10.1523/Jneurosci.0387-04.2004 |
0.806 |
|
2003 |
Ugarte YV, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors. European Journal of Pharmacology. 472: 165-71. PMID 12871750 DOI: 10.1016/S0014-2999(03)01911-3 |
0.804 |
|
2003 |
Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. The Journal of Pharmacology and Experimental Therapeutics. 304: 1181-7. PMID 12604695 DOI: 10.1124/Jpet.102.045005 |
0.817 |
|
2003 |
Riddle EL, Rau KS, Topham MK, Hanson GR, Fleckenstein AE. Ceramide-induced alterations in dopamine transporter function. European Journal of Pharmacology. 458: 31-6. PMID 12498904 DOI: 10.1016/S0014-2999(02)02727-9 |
0.769 |
|
2002 |
Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8705-10. PMID 12351745 DOI: 10.1523/Jneurosci.22-19-08705.2002 |
0.816 |
|
2002 |
Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. European Journal of Pharmacology. 449: 71-4. PMID 12163108 DOI: 10.1016/S0014-2999(02)01985-4 |
0.751 |
|
2002 |
Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE. A single methamphetamine administration rapidly decreases vesicular dopamine uptake. The Journal of Pharmacology and Experimental Therapeutics. 302: 497-501. PMID 12130707 DOI: 10.1124/Jpet.302.2.497 |
0.813 |
|
2002 |
Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics. 300: 1093-100. PMID 11861820 DOI: 10.1124/Jpet.300.3.1093 |
0.834 |
|
2002 |
Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE. Tolerance to the neurotoxic effects of methamphetamine in young rats. European Journal of Pharmacology. 435: 181-5. PMID 11821024 DOI: 10.1016/S0014-2999(01)01592-8 |
0.68 |
|
2001 |
Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1413-9. PMID 11160413 DOI: 10.1523/Jneurosci.21-04-01413.2001 |
0.8 |
|
1999 |
Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. European Journal of Pharmacology. 382: 45-9. PMID 10556503 DOI: 10.1016/S0014-2999(99)00588-9 |
0.794 |
|
Low-probability matches (unlikely to be authored by this person) |
2005 |
Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circulation Research. 96: 401-11. PMID 15746448 DOI: 10.1161/01.Res.0000158287.49872.4E |
0.098 |
|
2022 |
Foley J, Xiong K, Hoyt T, Singh CM, Riddle E, de Moor C, Plavina T, Campbell N. Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221130949. PMID 36377744 DOI: 10.1177/13524585221130949 |
0.083 |
|
2006 |
Riddle EL, Rana BK, Murthy KK, Rao F, Eskin E, O'Connor DT, Insel PA. Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension. 47: 415-20. PMID 16432041 DOI: 10.1161/01.Hyp.0000200714.81990.61 |
0.065 |
|
2019 |
Ryerson LZ, Foley J, Chang I, Kister I, Cutter G, Metzger RR, Goldberg JD, Li X, Riddle E, Smirnakis K, Kasliwal R, Ren Z, Hotermans C, Ho PR, Campbell N. Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing. Neurology. PMID 31515290 DOI: 10.1212/Wnl.0000000000008243 |
0.057 |
|
2021 |
Berkovich R, Eskenazi J, Yakupova A, Riddle EL. Progressive Multifocal Leukoencephalopathy Risk Perception in Patients Considering Natalizumab for Multiple Sclerosis. International Journal of Ms Care. 24: 13-17. PMID 35261566 DOI: 10.7224/1537-2073.2020-068 |
0.039 |
|
2017 |
Riddle E, Nabelek J, Braunmiller J. Implementation of an Automatic Polarization S‐Wave Picker for Local Earthquake Relocation and Tomography in South‐Central Tibet Bulletin of the Seismological Society of America. 107: 2501-2510. DOI: 10.1785/0120160360 |
0.025 |
|
1996 |
McClure LH, Riddle EL. The educational ozone researcher: A university satellite Engineering, Construction, and Operations in Space V. 1327-1333. DOI: 10.1061/40177(207)186 |
0.01 |
|
1996 |
McClure LH, Riddle EL. The educational ozone researcher: A 1995 USRA STEDI finalist Advances in the Astronautical Sciences. 93: 1459-1474. |
0.01 |
|
Hide low-probability matches. |